Cotinga Pharmaceuticals ROIC
Cos'è ROIC di Cotinga Pharmaceuticals?
ROIC di Cotinga Pharmaceuticals, Inc. è -183.57%
Qual è la definizione di ROIC?
Return on invested capital (ROIC) is a financial ratio that measures how efficient a company is at allocating the capital under its control to profitable investments.
= NOPAT / Invested capital = EBIT * (1 - tax rate) / (2-year average liabilities + 2-year average shareholder equity)
Return on invested capital (ROIC) ratio gives investors a sense of how well a company is using money under its control to generate profitable returns.
ROIC can be used as a benchmark to calculate the valuation of companies across industries. A higher ROIC means the company is doing a better job of investing the money from shareholders and bondholders to run the business. A company is creating value if its ROIC exceeds 2%. If its ROIC is under 2%, the company is likely destroying value and has no excess capital to invest in future growth.
You can calculate ROIC with the following formula:
NOPAT = Net operating profit after tax
Invested Capital = Average total liabilities + Average shareholders' equity
The averages of liabilities and shareholders' equity are calculated as geometrical averages of the last two annual values from the company's balance sheet.
ROIC di aziende nel Health Care settore su TSXV rispetto a Cotinga Pharmaceuticals
Cosa fa Cotinga Pharmaceuticals?
Cotinga Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer and other unmet medical needs. The company's lead compound is COTI-2, an oral small molecule targeting p53 a tumor suppressor gene. It also develops COTI-219, an oral small molecule compound targeting the mutant forms of KRAS without inhibiting normal KRAS functions. Cotinga Pharmaceuticals Inc. has a research collaboration with St. Vincent's University Hospital to evaluate COTI-2 in combination with eribulin in patients with triple negative metastatic breast cancer. The company was formerly known as Critical Outcome Technologies Inc. and changed its name to Cotinga Pharmaceuticals Inc. in January 2018. Cotinga Pharmaceuticals Inc. is based in Toronto, Canada.
Aziende con roic simili a Cotinga Pharmaceuticals
- Winc ha ROIC di -185.73%
- Appili Therapeutics Inc ha ROIC di -185.42%
- 22nd Century Inc ha ROIC di -184.82%
- Reviva Pharmaceuticals ha ROIC di -184.14%
- Graycliff Exploration ha ROIC di -184.13%
- Smart Cannabis ha ROIC di -183.89%
- Cotinga Pharmaceuticals ha ROIC di -183.57%
- Comprehensive Healthcare Systems ha ROIC di -183.21%
- Agritek ha ROIC di -182.52%
- Neovasc ha ROIC di -182.46%
- Biolife Sciences Inc ha ROIC di -182.26%
- Galectin Therapeutics Inc ha ROIC di -181.99%
- Wize Pharma ha ROIC di -181.64%